Table 2. – Demographic and laboratory information of CC-Dys patients according to death or heart transplantation.
| No events | Events | p-value | |
|---|---|---|---|
| (n=69) | (n=28) | ||
| Age (y) | 49 [42-54] | 47.5 [44.5-52] | 0.96 |
| Male, n (%) | 42 (61%) | 16 (57%) | 0.73 |
| Creatinine (mg/dL) | 1.01 [0.85-1.14] | 1.14 [0.87-1.23] | 0.06 |
| Ejection fraction (%) | 35 [25-40] | 20 [20-30] | 0.001 |
| NYHA >1 | 29 | 20 | 0.009 |
| Galectin-3 (ng/mL) | 14.4 [10.9-19.1] | 18.5 [14.7-23.4] | 0.005 |
| Low | 39 | 7 | |
| High | 30 | 21 | |
| NT-proBNP (pg/mL) | 542 [281-1337] | 2643 [1047-4771] | <0.001 |
| Low | 50 | 7 | |
| High | 19 | 21 | |
| Parasite estimate* | 1.77 [0.19-4.2] | 1.25 [0.16-12.61] | 0.08 |
Median [25th, 75th percentile) by death or heart transplantation as an outcome. CC-Dys: patients with positive T. cruzi serology and CC with left ventricular dysfunction; NT-proBNP: N-terminal pro B-type natriuretic peptide; NYHA: New York Heart Association. Low Galectin-3 = <15.3 ng/mL; Low NT-proBNP = <1278 pg/mL. *Parasite load per 20mL.